Viral immunogenic footprints conferring T cell cross-protection to SARS-CoV-2 and its variants

3Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.
Get full text

Abstract

COVID-19 brought scenes from sci-fi movies into real life. Infected individuals include asymptomatic cases to severe disease leading to death, suggesting the involvement of the genetic constitution of populations and pathogens contributing to differential individuals’ outcomes. To investigate shared immunogenic features between SARS-CoV-2 targets and other coronaviruses, we modeled their peptides in 3D structures of HLA-A*02:01 (pMHC), comparing their molecular surfaces These structures were also compared with a panel of epitopes from unrelated viruses, looking for potential triggers conferring cross-protection in uninfected individuals. As expected, SARS-CoV 1 and 2 peptides share molecular and physicochemical features, providing an explanation for the verified experimental immunogenicity among them. Surprisingly, even discordant sequences from human coronaviruses 229E, OC43 and epitopes from unrelated viruses involved in endemic human infections exhibit similar fingerprints of immunogenicity with SARS-CoV-2 peptides. The same approach indicates a conserved CD8+ T cell recognition between Wuhan SARS-CoV-2 sequences and altered peptides from Variants of Concern. Examination of structural data over epitope sequence analysis here could explain how previous infections may produce a heterologous immunity response in a global scale against emergent diseases such as Covid-19, mitigating its full lethal potential, and paves the way for the development of wide spectrum vaccine development.

References Powered by Scopus

A new coronavirus associated with human respiratory disease in China

8312Citations
N/AReaders
Get full text

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

1734Citations
N/AReaders
Get full text

The Immune Epitope Database (IEDB): 2018 update

1368Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8<sup>+</sup> T cell responses post SARS-CoV-2 infection

55Citations
N/AReaders
Get full text

SARS-CoV-2, periodontal pathogens, and host factors: The trinity of oral post-acute sequelae of COVID-19

1Citations
N/AReaders
Get full text

Unveiling cross-reactivity: implications for immune response modulation in cancer

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Antonio, E. C., Meireles, M. R., Bragatte, M. A. de S., & Vieira, G. F. (2022). Viral immunogenic footprints conferring T cell cross-protection to SARS-CoV-2 and its variants. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.931372

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

86%

Researcher 1

14%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 3

43%

Immunology and Microbiology 2

29%

Pharmacology, Toxicology and Pharmaceut... 1

14%

Medicine and Dentistry 1

14%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 39

Save time finding and organizing research with Mendeley

Sign up for free